BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9349397)

  • 1. Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels.
    Delpón E; Valenzuela C; Gay P; Franqueza L; Snyders DJ; Tamargo J
    Cardiovasc Res; 1997 Aug; 35(2):341-50. PubMed ID: 9349397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of block of a human cloned potassium channel by the enantiomers of a new bradycardic agent: S-16257-2 and S-16260-2.
    Delpón E; Valenzuela C; Pérez O; Franqueza L; Gay P; Snyders DJ; Tamargo J
    Br J Pharmacol; 1996 Mar; 117(6):1293-301. PubMed ID: 8882628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of descarboethoxyloratadine, the major metabolite of loratadine, on the human cardiac potassium channel Kv1.5.
    Caballero R; Delpón E; Valenzuela C; Longobardo M; Franqueza L; Tamargo J
    Br J Pharmacol; 1997 Nov; 122(5):796-8. PubMed ID: 9384491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of rupatadine, a new dual antagonist of histamine and platelet-activating factor receptors, on human cardiac kv1.5 channels.
    Caballero R; Valenzuela C; Longobardo M; Tamargo J; Delpón E
    Br J Pharmacol; 1999 Nov; 128(5):1071-81. PubMed ID: 10556945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaine enantiomers.
    Valenzuela C; Delpón E; Tamkun MM; Tamargo J; Snyders DJ
    Biophys J; 1995 Aug; 69(2):418-27. PubMed ID: 8527655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of propafenone and 5-hydroxy-propafenone on hKv1.5 channels.
    Franqueza L; Valenzuela C; Delpón E; Longobardo M; Caballero R; Tamargo J
    Br J Pharmacol; 1998 Nov; 125(5):969-78. PubMed ID: 9846634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of the nonsedating antihistamine loratadine with a Kv1.5-type potassium channel cloned from human heart.
    Lacerda AE; Roy ML; Lewis EW; Rampe D
    Mol Pharmacol; 1997 Aug; 52(2):314-22. PubMed ID: 9271355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of mibefradil block of the human heart delayed rectifier hKv1.5.
    Perchenet L; Clément-Chomienne O
    J Pharmacol Exp Ther; 2000 Nov; 295(2):771-8. PubMed ID: 11046117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loratadine blockade of K(+) channels in human heart: comparison with terfenadine under physiological conditions.
    Crumb WJ
    J Pharmacol Exp Ther; 2000 Jan; 292(1):261-4. PubMed ID: 10604956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations.
    Caballero R; Gómez R; Núñez L; Moreno I; Tamargo J; Delpón E
    Cardiovasc Res; 2004 Dec; 64(3):457-66. PubMed ID: 15537499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct block of cloned hKv1.5 channel by cytochalasins, actin-disrupting agents.
    Choi BH; Park JA; Kim KR; Lee GI; Lee YT; Choe H; Ko SH; Kim MH; Seo YH; Kwak YG
    Am J Physiol Cell Physiol; 2005 Aug; 289(2):C425-36. PubMed ID: 15800051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of nonsedating histamine H1 receptor antagonists, ebastine and terfenadine, on human Kv1.5 channels.
    Valenzuela C; Delpón E; Franqueza L; Gay P; Vicente J; Tamargo J
    Eur J Pharmacol; 1997 May; 326(2-3):257-63. PubMed ID: 9196279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzocaine enhances and inhibits the K+ current through a human cardiac cloned channel (Kv1.5).
    Delpón E; Caballero R; Valenzuela C; Longobardo M; Snyders D; Tamargo J
    Cardiovasc Res; 1999 May; 42(2):510-20. PubMed ID: 10533586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of block of a human cardiac potassium channel by terfenadine racemate and enantiomers.
    Yang T; Prakash C; Roden DM; Snyders DJ
    Br J Pharmacol; 1995 May; 115(2):267-74. PubMed ID: 7670728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization.
    Moreno I; Caballero R; González T; Arias C; Valenzuela C; Iriepa I; Gálvez E; Tamargo J; Delpón E
    J Pharmacol Exp Ther; 2003 Feb; 304(2):862-73. PubMed ID: 12538844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5.
    Perchenet L; Hilfiger L; Mizrahi J; Clément-Chomienne O
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1108-19. PubMed ID: 11504808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sensitivity of the human Kv1.3 (hKv1.3) lymphocyte K+ channel to regulation by PKA and PKC is partially lost in HEK 293 host cells.
    Martel J; Dupuis G; Deschênes P; Payet MD
    J Membr Biol; 1998 Jan; 161(2):183-96. PubMed ID: 9435274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate-dependent blockade of a potassium current in human atrium by the antihistamine loratadine.
    Crumb WJ
    Br J Pharmacol; 1999 Feb; 126(3):575-80. PubMed ID: 10188966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoxetine blocks cloned neuronal A-type K+ channels Kv1.4.
    Choi BH; Choi JS; Ahn HS; Kim MJ; Rhie DJ; Yoon SH; Min DS; Jo YH; Kim MS; Hahn SJ
    Neuroreport; 2003 Dec; 14(18):2451-5. PubMed ID: 14663209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bupivacaine and a novel local anesthetic, IQB-9302, on human cardiac K+ channels.
    González T; Longobardo M; Caballero R; Delpón E; Tamargo J; Valenzuela C
    J Pharmacol Exp Ther; 2001 Feb; 296(2):573-83. PubMed ID: 11160646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.